APLT: Applied Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Applied Therapeutics Inc (APLT).
$99.62M Market Cap.
APLT Market Cap. (MRY)
APLT Shares Outstanding (MRY)
APLT Assets (MRY)
Total Assets
$86.69M
Total Liabilities
$29.68M
Total Investments
$0
APLT Income (MRY)
Revenue
$455.00K
Net Income
-$105.62M
Operating Expense
$104.75M
APLT Cash Flow (MRY)
CF Operations
-$84.31M
CF Investing
$0
CF Financing
$113.81M
APLT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $86,691,000 (58.10%) | $54,833,000 (42.93%) | $38,363,000 (-57.32%) | $89,892,000 (-13.98%) |
Assets Current | $83,646,000 (53.80%) | $54,386,000 (45.78%) | $37,308,000 (-57.79%) | $88,394,000 (-13.84%) |
Assets Non-Current | $3,045,000 (581.21%) | $447,000 (-57.63%) | $1,055,000 (-29.57%) | $1,498,000 (-21.69%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $57,006,000 (432.47%) | -$17,146,000 (-522.21%) | $4,061,000 (-93.51%) | $62,539,000 (-23.68%) |
Property Plant & Equipment Net | $2,792,000 (524.61%) | $447,000 (-47.84%) | $857,000 (-33.98%) | $1,298,000 (-24.18%) |
Cash & Equivalents | $79,398,000 (59.12%) | $49,898,000 (199.56%) | $16,657,000 (-69.09%) | $53,888,000 (-6.23%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $51,000 (147.66%) | -$107,000 (4.46%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $13,923,000 (-48.31%) | $26,935,000 (-31.57%) |
Investments Current | $0 (0%) | $0 (0%) | $13,923,000 (-48.31%) | $26,935,000 (-31.57%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,433,000 (154.48%) | $1,742,000 (-61.58%) | $4,534,000 (-52.08%) | $9,461,000 (1378.28%) |
Accumulated Retained Earnings (Deficit) | -$574,210,000 (-22.54%) | -$468,586,000 (-34.33%) | -$348,823,000 (-30.98%) | -$266,315,000 (-65.69%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $2,795,000 (498.50%) | $467,000 (-47.59%) | $891,000 (-33.16%) | $1,333,000 (-23.30%) |
Debt Current | $406,000 (-5.36%) | $429,000 (-10.06%) | $477,000 (7.92%) | $442,000 (8.87%) |
Debt Non-Current | $2,389,000 (6186.84%) | $38,000 (-90.82%) | $414,000 (-53.54%) | $891,000 (-33.11%) |
Total Liabilities | $29,685,000 (-58.76%) | $71,979,000 (109.84%) | $34,302,000 (25.40%) | $27,353,000 (21.21%) |
Liabilities Current | $27,296,000 (-61.65%) | $71,182,000 (112.97%) | $33,424,000 (26.31%) | $26,462,000 (24.62%) |
Liabilities Non-Current | $2,389,000 (199.75%) | $797,000 (-9.23%) | $878,000 (-1.46%) | $891,000 (-33.11%) |
APLT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $455,000 (-95.45%) | $9,993,000 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $56,010,000 (171.59%) | $20,623,000 (-24.50%) | $27,316,000 (-36.55%) | $43,048,000 (31.73%) |
Research & Development Expense | $48,744,000 (-9.57%) | $53,905,000 (-3.11%) | $55,634,000 (-11.09%) | $62,570,000 (1.27%) |
Operating Expenses | $104,754,000 (40.56%) | $74,528,000 (-10.15%) | $82,950,000 (-21.46%) | $105,618,000 (11.81%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$105,624,000 (11.81%) | -$119,763,000 (-45.15%) | -$82,508,000 (21.86%) | -$105,584,000 (-12.37%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$105,624,000 (11.81%) | -$119,763,000 (-45.15%) | -$82,508,000 (21.86%) | -$105,584,000 (-12.37%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$105,624,000 (11.81%) | -$119,763,000 (-45.15%) | -$82,508,000 (21.86%) | -$105,584,000 (-12.37%) |
Weighted Average Shares | $139,534,746 (65.63%) | $84,244,494 (122.72%) | $37,825,431 (47.77%) | $25,598,181 (16.53%) |
Weighted Average Shares Diluted | $139,534,746 (65.63%) | $84,244,494 (122.72%) | $37,825,431 (47.77%) | $25,598,181 (16.53%) |
Earning Before Interest & Taxes (EBIT) | -$105,624,000 (11.81%) | -$119,763,000 (-45.15%) | -$82,508,000 (21.86%) | -$105,584,000 (-13.04%) |
Gross Profit | $455,000 (-95.45%) | $9,993,000 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$104,299,000 (-61.62%) | -$64,535,000 (22.20%) | -$82,950,000 (21.46%) | -$105,618,000 (-11.81%) |
APLT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $13,872,000 (5.33%) | $13,170,000 (5.93%) | $12,433,000 (163.86%) |
Net Cash Flow from Financing | $113,805,000 (52.67%) | $74,542,000 (169.18%) | $27,692,000 (-62.94%) | $74,717,000 (-45.18%) |
Net Cash Flow from Operations | -$84,305,000 (-52.80%) | -$55,173,000 (29.35%) | -$78,093,000 (13.93%) | -$90,728,000 (-16.01%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $29,500,000 (-11.25%) | $33,241,000 (189.28%) | -$37,231,000 (-940.55%) | -$3,578,000 (-109.27%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $13,872,000 (5.33%) | $13,170,000 (5.93%) | $12,433,000 (163.86%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | -$311,000 (0.32%) | -$312,000 (-85.71%) | -$168,000 (40.85%) | -$284,000 (-126.44%) |
Issuance (Purchase) of Equity Shares | $105,091,000 (62.67%) | $64,604,000 (131.89%) | $27,860,000 (-62.82%) | $74,932,000 (-44.87%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $13,467,000 (82.98%) | $7,360,000 (-23.36%) | $9,603,000 (-14.08%) | $11,177,000 (39.26%) |
Depreciation Amortization & Accretion | $425,000 (20.40%) | $353,000 (-19.95%) | $441,000 (6.27%) | $415,000 (9.21%) |
APLT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% | - | - |
Profit Margin | -23214.10% (-1836.93%) | -1198.50% | - | - |
EBITDA Margin | -23120.70% (-1834.95%) | -1194.90% | - | - |
Return on Average Equity (ROAE) | -208.60% (-115.94%) | 1309.00% (423.13%) | -405.10% (-280.73%) | -106.40% (-33.33%) |
Return on Average Assets (ROAA) | -89.50% (67.55%) | -275.80% (-98.99%) | -138.60% (-64.61%) | -84.20% (-22.21%) |
Return on Sales (ROS) | -23214.10% (-1836.93%) | -1198.50% | - | - |
Return on Invested Capital (ROIC) | 179.90% (-33.57%) | 270.80% (-48.76%) | 528.50% (250.78%) | -350.50% (-73.17%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.13 (52.23%) | -2.36 (-575.93%) | -0.35 (83.93%) | -2.17 (57.77%) |
Price to Sales Ratio (P/S) | 262.57 (829.71%) | 28.24 | - | - |
Price to Book Ratio (P/B) | 1.75 (111.58%) | -15.09 (-267.77%) | 8.99 (139.71%) | 3.75 (-37.89%) |
Debt to Equity Ratio (D/E) | 0.52 (112.41%) | -4.2 (-149.70%) | 8.45 (1832.95%) | 0.44 (58.91%) |
Earnings Per Share (EPS) | -0.76 (46.48%) | -1.42 (34.86%) | -2.18 (47.09%) | -4.12 (3.74%) |
Sales Per Share (SPS) | 0 (-97.48%) | 0.12 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.6 (7.79%) | -0.66 (68.28%) | -2.06 (41.73%) | -3.54 (0.45%) |
Book Value Per Share (BVPS) | 0.41 (300.49%) | -0.2 (-290.65%) | 0.11 (-95.62%) | 2.44 (-34.50%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.62 (-4.61%) | 0.65 (-35.80%) | 1.01 (-71.13%) | 3.51 (-26.19%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | -2 (0%) | 0 (0%) | -2 (60.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.03 (98.60%) | -1.86 (-5405.71%) | 0.04 (102.22%) | -1.58 (67.26%) |
Asset Turnover | 0 (-98.26%) | 0.23 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 3.06 (301.05%) | 0.76 (-31.54%) | 1.12 (-66.59%) | 3.34 (-30.86%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$84,305,000 (-52.80%) | -$55,173,000 (29.35%) | -$78,093,000 (13.93%) | -$90,728,000 (-16.01%) |
Enterprise Value (EV) | $2,728,413 (-98.77%) | $221,795,843 (7862.72%) | -$2,857,193 (-101.72%) | $165,860,850 (-62.98%) |
Earnings Before Tax (EBT) | -$105,624,000 (11.81%) | -$119,763,000 (-45.15%) | -$82,508,000 (21.86%) | -$105,584,000 (-12.37%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$105,199,000 (11.90%) | -$119,410,000 (-45.50%) | -$82,067,000 (21.97%) | -$105,169,000 (-13.06%) |
Invested Capital | -$17,208,000 (73.84%) | -$65,780,000 (-507.56%) | -$10,827,000 (-199.56%) | $10,875,000 (-60.52%) |
Working Capital | $56,350,000 (435.50%) | -$16,796,000 (-532.44%) | $3,884,000 (-93.73%) | $61,932,000 (-23.88%) |
Tangible Asset Value | $86,691,000 (58.10%) | $54,833,000 (42.93%) | $38,363,000 (-57.32%) | $89,892,000 (-13.98%) |
Market Capitalization | $99,624,413 (-61.49%) | $258,717,843 (608.33%) | $36,524,807 (-84.43%) | $234,628,850 (-52.60%) |
Average Equity | $50,646,000 (653.57%) | -$9,149,000 (-144.92%) | $20,365,250 (-79.48%) | $99,225,250 (-15.72%) |
Average Assets | $118,067,250 (171.92%) | $43,419,500 (-27.08%) | $59,543,250 (-52.52%) | $125,404,250 (-8.09%) |
Invested Capital Average | -$58,719,250 (-32.77%) | -$44,225,750 (-183.30%) | -$15,611,000 (-151.83%) | $30,122,000 (-34.71%) |
Shares | 116,356,474 (50.66%) | 77,229,207 (60.70%) | 48,058,956 (83.32%) | 26,215,514 (16.58%) |
